ストックスクリーナーアプリを入手
41.71
2.03%
0.83
アフターアワーズ：
42.90
1.19
+2.85%
Lineage Inc (LINE) 最新ニュース
Analysts Are Bullish on Top Real Estate Stocks: Equity Residential (EQR), Lineage, Inc. (LINE) - The Globe and Mail
Lineage reports positive 36-month findings on GA cell therapy - Eyes On Eyecare
Newsmaker: Greg Lehmkuhl - Crain's Detroit Business
LINE Stock Price, Quote & Chart | LINEAGE INC (NASDAQ:LINE) - ChartMill
Why Lineage, Inc. Stock Is Suddenly Climbing - TipRanks
What Lineage (LINE)'s Q1 Move From Profit to Loss Means For Shareholders - simplywall.st
Assessing Lineage (LINE) Valuation After Q1 Loss And Modest Undervaluation Signal - simplywall.st
Lineage Cell Therapeutics (LCTX) price target increased by 14.58% to 5.61 - MSN
The Leadership Lineage Behind Arkansas’ Largest Private Construction Company - Arkansas Business
Lineage, Inc. (LINE) Q1 FFO beat estimates - MSN
Earnings call transcript: Lineage Inc reports Q1 2026 earnings decline, stock dips - Investing.com Nigeria
Lineage, Inc. $LINE Stock Holdings Lifted by Charles Schwab Investment Management Inc. - MarketBeat
Oxford invests $474M in Lineage Logistics; Turner joins board - RENX
Lineage Logistics to acquire GTA-based VersaCold - RENX
Lineage Cell Therapeutics Q1 Earnings Call Highlights - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
All you need to know about Lineage, Inc. (LINE) rating upgrade to buy - MSN
NCSoft Posts Record PC Game Sales on Aion 2, Lineage Classic Success - thelec.net
NC's First-Quarter Operating Profit Surges 2,070% on Lineage Classic Success - thelec.net
Lineage Cell Therapeutics, Inc. Common Stock (NY: LCTX - FinancialContent
Q1 2026 Lineage Cell Therapeutics Inc Earnings Call Transcript - GuruFocus
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2026 Earnings Call Transcript - Insider Monkey
Lineage Q1 2026 slides: flat revenue, rising EBITDA amid stabilization By Investing.com - Investing.com South Africa
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - BioSpace
Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highl - GuruFocus
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Lineage Cell Therapeutics (NYSE: LCTX) reports higher Q1 2026 revenue and continued R&D spend - Stock Titan
Lineage Cell Therapeutics (LCTX) posts Q1 2026 results and advances cell therapy pipeline - Stock Titan
Lineage Cell: Q1 Earnings Snapshot - WKYC
Earnings call transcript: Lineage Inc reports mixed Q1 2026 results amid market volatility By Investing.com - Investing.com South Africa
Lineage Q1 2026 slides: flat revenue, rising EBITDA amid stabilization - Investing.com
Earnings call transcript: Lineage Inc reports mixed Q1 2026 results amid market volatility - Investing.com
Citigroup maintains Lineage (LINE) neutral recommendation - MSN
Lineage Cell Therapeutics Q1 2026 earnings preview - MSN
Lineage: Robots Could Add $30 Per Share (NASDAQ:LINE) - Seeking Alpha
A Look At Lineage (LINE) Valuation After Mixed Q1 2026 Results And Dividend Increase - simplywall.st
Lineage reiterates 2026 AFFO of $2.75 to $3.00 per share while targeting $50M+ cost savings - MSN
Lineage, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LINE) 2026-05-09 - Seeking Alpha
MSN Money - MSN
Lineage Is Maintained at In-Line by Evercore ISI Group - Moomoo
Lineage Q1 2026 earnings preview - MSN
Why Lineage (LINE) Is Up 8.4% After Beating FFO Estimates And Reaffirming 2026 Guidance - simplywall.st
Analysts Offer Insights on Real Estate Companies: Lineage, Inc. (LINE), Macerich (MAC) and Realty Income (O) - The Globe and Mail
Vanguard Group Inc. Sells 52,128 Shares of Lineage, Inc. $LINE - MarketBeat
Analysts Offer Insights on Real Estate Companies: Lineage, Inc. (LINE) and Frasers Logistics & Commercial Trust (OtherFRLOF) - The Globe and Mail
US Cold Storage Market Is Going to Boom Rapidly | Lineage - openPR.com
Number of shareholders of Lineage, Inc. – NASDAQ:LINE - TradingView
Lineage, Inc. Earnings Call Balances Progress And Risk - The Globe and Mail
Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation SummitSlideshow - Seeking Alpha
0.27%
1.20%
大文字化:
|
ボリューム (24 時間):